Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 37 | 23 | 12 | 38 | 33 |
| Cost of Goods | 20 | 13 | 7 | 15 | 10 |
| Gross Profit | 17 | 10 | 4 | 23 | 23 |
| Operating Expenses | 617 | 467 | 388 | 453 | 486 |
| Operating Income | -600 | -457 | -383 | -430 | -463 |
| Interest Expense | 49 | 21 | 30 | 28 | 27 |
| Other Income | 67 | -1 | 2 | 126 | 4 |
| Pre-tax Income | -581 | -478 | -412 | -333 | -487 |
| Net Income Continuous | -581 | -478 | -412 | -333 | -487 |
| Net Income | $-581 | $-478 | $-412 | $-333 | $-487 |
| EPS Basic Total Ops | -0.04 | -0.04 | -0.02 | -0.01 | -0.02 |
| EPS Basic Continuous Ops | -0.04 | -0.04 | -0.02 | -0.01 | -0.02 |
| EPS Diluted Total Ops | -0.04 | -0.04 | -0.02 | -0.01 | -0.02 |
| EPS Diluted Continuous Ops | -0.04 | -0.04 | -0.02 | -0.01 | -0.02 |
| EBITDA(a) | $-521 | $-445 | $-371 | $-295 | $-450 |